A coffee a day keeps cancer at bay

A coffee a day keeps cancer at bay

Drinking coffee reduces the risk of Liver cancer in a ‘dose-dependent manner – the more you drink, the more it reduces risk.
 
Researchers from the University of Southampton and the University of Edinburgh have found that this applies to both caffeinated coffee and (to a lesser extent) decaffeinated coffee. And the research was no small study – it was a meta-analysis of 26 previous studies involving more than 2 million people in total(1).
 
5 cups a day halved risk, 3 cups reduced in by 35 per cent and just one cup reduced risk by 20 per cent.
 
These results came soon after Italian Researchers showed real Italian Coffee could cut prostate cancer risk in half. 
 
Chris Woollams, former Oxford University Biochemist and Founder of CANCERactive said, “Coffee is a complex mix of bioactive natural compounds like flavonoids, phenols and diterpines – the latter having strong cancer correcting epigenetic properties. Core ingredients of real coffee are known to have anti-inflammatory, antioxidant, insulin-regulating and anti-cancer benefits. In both the above studies, however, a significant part of the benefit was linked to caffeine. But, a study in May 2011 by the Harvard School of Public Health(2) showed that drinking real coffee reduced the risk of an aggressive, lethal form of prostate cancer – and this was true whether it was caffeinated or decaffeinated. So other factors are clearly at work. 

 

 

 

We also know that real coffee consumption lowers levels of certain liver enzymes and the risk of cirrhosis.

 

 

 

Finally, 4-5 cups a day reduces Parkinson’s risk and type-2 diabetes risk. Contrary to popular belief, there may even be benefits against cardiovascular disease.”
 
 
Ref: 

 

1. http://www.southampton.ac.uk/news/2017/05/coffee-liver-study.page

 

2. Coffee Consumption and Prostate Cancer Risk and Progression in the Health Professionals Follow-up Study,” Kathryn M. Wilson, Julie L. Kasperzyk, Jennifer R. Stark, Stacey Kenfield, Rob M. van Dam,  Meir J. Stampfer, Edward Giovannucci, Lorelei A. Mucci, Journal of the National Cancer Institute, online May 17, 2011.
 
 
2017 Research
CancerAcitve Logo
Subscribe (Free e-Newsletter)

Join Our
Newsletter

Join Our Newsletter Signup today for free and be the first to get notified on new updates.